Pharmacy Medical News about hepatitis

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Predictive value of on-treatment response during full-dose antiviral therapy of patients with hepatitis C virus cirrhosis and portal hypertension
Journal of Internal Medicine, 10/28/09

Giannini EG et al. – Full–dose antiviral therapy with PEG–IFN and ribavirin can be safely carried out even in patients with compensated, fully established cirrhosis and portal hypertension. Selecting patients on the basis of HCV genotype and viral load, and application of on–treatment stopping rule may help rationalize treatment in patients who are unlikely to obtain SVR.

<< Previous
Appraisal of antinociceptive and anti-inflammatory potential of...

Next >>
Drug-Induced Encephalopathy Secondary to Non Renal Dosing of...

Sporadic cases of acute autochthonous hepatitis E virus infection in Southwest Germany
Journal of Clinical Virology, 11/16/09 Relevance Score: 91%

Liver enzyme abnormalities in systemic lupus erythematosus: A focus on toxic hepatitis
Rheumatology International, 11/13/09 Relevance Score: 91%

De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation
Liver Transplantation, 10/30/09 Relevance Score: 91%

Reactivation of Hepatitis B With Reappearance of Hepatitis B Surface Antigen After Chemotherapy and Immunosuppression
Clinical Gastroenterology and Hepatology, 10/09/09 Relevance Score: 91%

FOXP3 Expression in Hepatitis C Virus-Specific CD4+ T Cells During Acute Hepatitis C
Gastroenterology, 10/06/09 Relevance Score: 91%